America's Pharma Blame Game? Litigation May Cripple GLP-1 Revolution

GLP-1 drugs like Ozempic are transforming weight loss and diabetes management. But no good deed goes unpunished, and the manufacturers of these medicines now face a wave of lawsuits, with plaintiffs claiming they weren't warned about rare but sometimes serious side effects. Is this litigation driven by solid evidence, or are the tort lawyers out for yet another unearned payday? Let's take a look.

Episode metadata supplied by the publisher feed · Published Jun 2, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

America's Pharma Blame Game? Litigation May Cripple GLP-1 Revolution

0:00 23:37

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of ACSH Science Dispatch?

This episode is 23 minutes long.

When was this ACSH Science Dispatch episode published?

This episode was published on June 2, 2025.

Can I download this ACSH Science Dispatch episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!